SCHEMBL13359695

SCHEMBL13359695

COc1ccc(CNc2nc(NCc3ccc(OC)c(OC)c3)nc(NC3CCCCC3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.57
ACHE P22303 3/20 0.57
BCHE P06276 2/20 0.57
MAPT P10636 3/20 0.54
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
GAA P10253 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.49
CTSS P25774 2/20 0.48
CTSK P43235 2/20 0.48
CTSL P07711 1/20 0.48
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3292645 0.94 APP (0.62) APPACHEBCHEMAPTALDH1A1
SCHEMBL13325984 0.91 CTSS (0.49) APPACHEBCHEMAPTALDH1A1
SCHEMBL3290340 0.91 CTSL (0.57) APPACHEBCHEMAPTALDH1A1
SCHEMBL3287378 0.91 CTSS (0.56) ACHEALDH1A1KDM4ETDP1SMN1; SMN2
SCHEMBL13325957 0.89 CTSS (0.54) ACHEALDH1A1KDM4ETDP1SMN1; SMN2
SCHEMBL13326056 0.89 ACHE (0.57) APPACHEBCHEMAPTALDH1A1
SCHEMBL3293389 0.86 SMN1; SMN2 (0.53) MAPTALDH1A1GAATDP1SMN1; SMN2
SCHEMBL13326070 0.85 PDE4A (0.53) ACHEALDH1A1TDP1SMN1; SMN2CTSS
SCHEMBL3287809 0.84 CTSL (0.54) MAPTALDH1A1KDM4ETDP1MEN1
SCHEMBL3289389 0.84 CTSL (0.68) MAPTALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718655-B2 Trisubstituted triazine compounds, and methods for making and using the compounds, which have antitubulin activity NEW YORK UNIVERSITY (US) 2010-05-18 US disclosed